IL2 and neoplasm: Third, in part due to this high affinity for the trimeric high-affinity receptor complex on immunosuppressive Tregs, a higher dose of IL-2 is necessary to achieve CTL-mediated immune killing of the tumor, which leads to severe toxicity in most patients2.